Clinical Trial Update: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a conditioning regimen of busulfan, melphalan, and topotecan hydrochloride followed by stem cell transplantation in patients with newly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma
• Cerebellar Astrocytoma
• Cerebral Astrocytoma
• Ewing Sarcoma
• Extragonadal Germ Cell Tumor
• Medulloblastoma
• Ovarian Germ Cell Tumor
• Rhabdomyosarcoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Melphalan (Melphalan)
• Topotecan hydrochloride (topotecan hydrochloride)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Solid Tumor, Adult Central Nervous System Germ Cell Tumor | Phase 1 | Status: COMPLETED